SCHEMBL6411294

SCHEMBL6411294

O=C1OCC(CN2CCC(Cc3cc(F)ccc3Br)CC2)CN1C1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 7/20 0.42
HTR1A P08908 5/20 0.39
RAB9A P51151 1/20 0.36
OPRM1 P35372 2/20 0.36
OPRK1 P41145 2/20 0.36
OPRL1 P41146 2/20 0.36
CCR8 P51685 1/20 0.35
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
DRD2 P14416 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
PER2 O15055 2/20 0.34
DPP4 P27487 1/20 0.33
CCR3 P51677 1/20 0.33
CCR5 P51681 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6414509 0.91 SLC6A4 (0.42) SLC6A4HTR1ARAB9A
SCHEMBL6412284 0.89 RAB9A (0.36) SLC6A4HTR1ARAB9AOPRM1OPRK1
SCHEMBL6410283 0.89 HTR1A (0.39) SLC6A4HTR1AOPRM1OPRK1OPRL1
SCHEMBL6415359 0.86 SLC6A4 (0.51) SLC6A4HTR1ACCR8
SCHEMBL6412400 0.86 HTR2B (0.48) SLC6A4HTR1ARAB9AOPRM1OPRK1
SCHEMBL6412593 0.85 HTR1A (0.49) SLC6A4HTR1ACCR8
SCHEMBL6435066 0.84 SLC6A4 (0.42) SLC6A4HTR1ADRD2SIGMAR1CCR3
SCHEMBL6412692 0.84 SLC6A4 (0.50) SLC6A4HTR1ACCR8
SCHEMBL6416894 0.82 SLC6A4 (0.44) SLC6A4HTR1ADPP4
SCHEMBL6412127 0.82 SLC6A4 (0.42) SLC6A4HTR1ACCR3CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065140-A1 Serotonine reuptake inhibitor SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2005-03-24 US disclosed
EP-1466901-A1 SEROTONINE REUPTAKE INHIBITOR SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065140-A1 Serotonine reuptake inhibitor HTR1A, SLC6A4, SLC6A2 SLC6A4 2/4885HTR1A 1/4885RAB9A 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.